DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) announced that the Company and its collaborators from the University of Texas MD Anderson Cancer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE